Medical Device and Healthcare Products Export: Regulation and Markets

The Turkish Medical Device Sector: A Rising Force in Healthcare

Turkey's medical device and healthcare products sector has begun to command an increasingly significant voice in global markets, driven by rapid growth over the past decade. In 2025, Turkish medical device exports reached $3.8 billion, representing an 18 percent increase over the previous year.

More than 1,500 manufacturing firms operate in the sector, a significant proportion of which meet international quality standards. Turkey's robust healthcare infrastructure, growing domestic market, and strategic geographic location are the fundamental factors supporting the medical device sector's export potential.

The global medical device market exceeded $600 billion in 2025, and annual growth of 5 to 6 percent is projected through 2030. Turkey is taking strategic steps to increase its share of this enormous market. Health technologies will be one of the fastest-growing sectors of the coming decade.

The Turkish Medical Sector's Product Portfolio

Medical Consumables

Medical consumables constitute the largest component of Turkish medical exports:

• Syringes and needles: Turkey is among the world leaders in disposable syringe production
• IV sets and infusion supplies: IV sets, cannulas, and connectors
• Surgical consumables: Surgical gloves, gowns, masks, drapes, and sutures
• Wound care products: Wound dressings, bandages, and adhesive tapes
• Diagnostic kits: Rapid diagnostic tests, laboratory kits, and reagents

Medical Devices and Equipment

Imaging systems: Ultrasound devices, digital X-ray systems, and patient monitoring units. The medical device division within Arcelik A.S. and various domestic companies produce in this area.

Surgical instruments: General surgery, orthopedic, ophthalmic, and dental instruments. Turkish manufacturers offer high quality and competitive pricing, particularly in surgical hand instruments.

Orthopedic implants: Hip and knee prostheses, spinal implants, trauma plates, and screws. This segment contains R&D-intensive, high-value-added products.

Dental products: Dental implants, dental units, sterilization equipment, and prosthetic materials. The Turkish dental sector holds a globally competitive position, especially in implant manufacturing.

Hospital furniture: Patient beds, operating tables, examination tables, and transport equipment. Turkish manufacturers stand out in this segment with their broad product range and competitive pricing.

Personal Protective Equipment (PPE)

Following the COVID-19 pandemic, Turkey significantly expanded its PPE production capacity:

• Medical masks and N95/FFP2 respirators
• Protective coveralls and gowns
• Face shields and protective goggles
• Medical gloves

CE Marking and EU Regulations

European Medical Device Regulation (MDR)

For medical device exports to the EU, the MDR (Medical Device Regulation 2017/745), which took effect from 2021, has significantly tightened regulatory requirements.

Core MDR requirements:

• Classification: Devices are classified as Class I, IIa, IIb, and III based on their risk level
• Clinical evaluation: Clinical data requirements have been heightened for all devices
• Technical file: Comprehensive technical documentation must be prepared
• UDI (Unique Device Identification): A mandatory unique device identification system
• Post-market surveillance: Post-market surveillance and vigilance reporting obligations
• Authorized representative: Manufacturers outside the EU must appoint an authorized representative within the EU

Notified Body process:

A Notified Body audit is mandatory for all devices except Class I. Under the MDR, the number of Notified Bodies has decreased and audit timelines have lengthened. The certification process can take an average of 12 to 24 months. Early planning of this process is critically important.

In Vitro Diagnostic Regulation (IVDR)

The IVDR (2017/746) applies to in vitro diagnostic devices (laboratory tests, rapid diagnostic kits, etc.). The IVDR has completely overhauled the classification system compared to the previous directive and introduced stricter requirements:

• A new four-class risk categorization: Class A, B, C, and D
• Performance evaluation through reference laboratories
• Expanded requirements for clinical performance studies

The CE Marking Process

1. Product classification: Determining the device's risk class under MDR/IVDR
2. Identification of applicable standards: Harmonized standards such as EN ISO 13485 and IEC 60601
3. Quality management system: ISO 13485 certification
4. Technical file preparation: Comprehensive documentation covering design, manufacturing, testing, and clinical evaluation data
5. Clinical evaluation: Clinical data analysis and/or clinical investigation
6. Conformity assessment: Notified Body audit (for devices other than Class I)
7. EU Declaration of Conformity: Preparation of the manufacturer's declaration of conformity
8. CE marking affixation: Placing the CE mark on the product
9. EUDAMED registration: Registration in the EU medical device database

FDA Approval and the US Market

FDA Regulatory Pathways

FDA (Food and Drug Administration) approval is mandatory for entry into the US market. The FDA regulatory process follows different pathways depending on the device's classification:

Class I devices: General controls are sufficient. Premarket notification is not required for most. Establishment registration and device listing are mandatory.

Class II devices — 510(k) pathway: When a similar (predicate) device exists on the market, a 510(k) premarket notification is submitted. The device must demonstrate "substantial equivalence" to an existing device. Average review time is 3 to 12 months.

Class III devices — PMA pathway: Premarket Approval (PMA) applications are required for devices in the highest risk class. Clinical study data is mandatory, and review times range from 12 to 36 months.

De Novo classification: An alternative pathway for novel devices that are low to moderate risk but lack a predicate device on the market.

FDA Registration Requirements

• Establishment Registration: Registration of the manufacturing facility with the FDA
• Device Listing: Listing of manufactured devices with the FDA
• US Agent: Appointment of a US agent for manufacturers outside the United States
• MDR (Medical Device Reporting): Adverse event reporting obligations
• QSR (Quality System Regulation): Compliance with the 21 CFR Part 820 quality system

US Market Size

The United States is the largest market, accounting for approximately 40 percent of the global medical device market. In 2025, the US medical device market exceeded $220 billion. While entry into this market is difficult and costly, the returns for successful companies are exceptionally high.

Other Key Markets and Regulations

Middle East and Gulf States

The Gulf states are among the fastest-growing markets for Turkish medical device exports. Saudi Arabia's SFDA (Saudi Food and Drug Authority) and the UAE's Emirates Authority for Standardization regulations largely recognize EU CE marking.

Market opportunities:

• Saudi Arabia's healthcare infrastructure modernization (Vision 2030)
• The UAE's goal of becoming a medical tourism hub
• Hospital investments in Qatar and Kuwait
• Regional localization policies (local manufacturing opportunities)

Africa

The African continent is one of the regions with the highest growth potential in the medical device market. Inadequate healthcare infrastructure, a growing population, and international health aid are driving demand.

• Strong demand for low- to medium-technology devices and consumables
• Tender processes of international donor organizations
• Local regulatory requirements that vary from country to country
• High price sensitivity

Turkic Republics and CIS

Cultural proximity and commercial relationships provide Turkish medical device companies with advantages in these markets. Turkish products are particularly preferred in hospital furniture, consumables, and basic medical devices.

Quality Management and Certifications

ISO 13485

ISO 13485 is the international quality management system standard for medical device manufacturers. This certification is a prerequisite for entry into medical device markets worldwide:

• Design and development controls
• Supplier management
• Production and process validation
• Sterilization validation
• Risk management (ISO 14971)
• Traceability and recall procedures

GMP (Good Manufacturing Practice)

Good Manufacturing Practices define the fundamental quality requirements in medical device production. The FDA's QSR (Quality System Regulation) requirements and EU MDR requirements are grounded in GMP principles.

Sterilization Validation

Sterilization process validation is mandatory for sterile medical devices:

• Ethylene oxide (EtO) sterilization — EN ISO 11135
• Radiation sterilization — EN ISO 11137
• Steam sterilization — EN ISO 17665
• Sterile barrier systems — EN ISO 11607

Sector Support and Incentives

Government Support

The Turkish government has designated the medical device sector among its strategically prioritized industries:

• Investment incentives: Tax reductions and social security premium support under technology-intensive investment incentive certificates
• R&D support: TUBITAK 1501 and 1505 programs, KOSGEB R&D and innovation grants
• Export support: Trade fair participation support, market research grants, and certification support
• Cluster support: Organizational and financial support for medical device clusters

Free Zone Advantages

Free zones in Turkey offer various advantages for medical device manufacturing:

• Income and corporate tax exemptions
• VAT and customs duty exemptions
• Freedom to transfer profits
• Regulatory facilitation

Growth Strategies

1. R&D and Innovation

Sustaining competitiveness in the medical device sector depends on continuous R&D and innovation:

• New product development through university-industry collaborations
• Medical device R&D centers in technology development zones
• Strengthening the patent and intellectual property portfolio
• Digital health technologies and artificial intelligence applications

2. Clinical Research Capacity

MDR and FDA requirements have increased the need for clinical data. Turkey's strong clinical research infrastructure and patient population provide an advantage in this area. Collaborations with clinical research centers will accelerate product development processes.

3. Digital Health and Artificial Intelligence

Telemedicine, AI-powered diagnostic systems, wearable health devices, and remote patient monitoring technologies are the fastest-growing segments in the medical device sector. Developing competence in these areas will form the foundation of future competitive advantage.

4. Market Diversification

Avoid dependency on a single market by building a balanced export portfolio across the EU, US, Middle East, Africa, and Asia. Develop separate strategies for compliance with each market's regulatory requirements.

5. International Partnerships

Establish partnerships with international firms through technology transfer, joint ventures, and licensing agreements. Such collaborations can enhance both technological competence and market access.

Conclusion: Turkey's Future in Medical Devices

The Turkish medical device sector possesses significant growth potential in global markets, backed by strong manufacturing infrastructure, increasing R&D capacity, and competitive costs. Growing expertise in CE marking and FDA approval processes is strengthening access to international markets.

For the sector's sustainable growth, regulatory compliance, quality management, R&D investments, and market diversification strategies must be implemented simultaneously. Rising global healthcare expenditures and the transformation in health technologies present significant opportunities for Turkish medical device companies. Firms that capitalize on these opportunities will join the ranks of the sector's global players over the coming decade.